We specialize in the development of methods for:
Bioanalytical part of clinical studies
Identification of active ingredients of medicinal product by comparing their mass-spectrum with mass-spectrum of corresponding pharmacopoeia standard samples
Monitoring of impurities of active pharmaceutical ingredients on ppm level
In plans for development of the Bioanalytical laboratory there are increasing the number of LC-MS/MS systems and supplementary analytic equipment, employees’ qualification growth, implementation of proteomic technologies and utilize the LC-MS/MS technologies for diseases biomarker determination and therapeutic drug monitoring.